Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Novel Mutation of the RUNX2 Gene in Patients with Cleidocranial Dysplasia.

Hordyjewska E, Jaruga A, Kandzierski G, Tylzanowski P.

Mol Syndromol. 2017 Aug;8(5):253-260. doi: 10.1159/000477307. Epub 2017 Jun 15.

2.

Inhibition of nuclear Wnt signalling: challenges of an elusive target for cancer therapy.

Lyou Y, Habowski AN, Chen GT, Waterman ML.

Br J Pharmacol. 2017 Dec;174(24):4589-4599. doi: 10.1111/bph.13963. Epub 2017 Aug 24. Review.

3.

Fine-Tuning of the Kaposi's Sarcoma-Associated Herpesvirus Life Cycle in Neighboring Cells through the RTA-JAG1-Notch Pathway.

Li S, Hu H, He Z, Liang D, Sun R, Lan K.

PLoS Pathog. 2016 Oct 19;12(10):e1005900. doi: 10.1371/journal.ppat.1005900. eCollection 2016 Oct.

4.

RNF4-Dependent Oncogene Activation by Protein Stabilization.

Thomas JJ, Abed M, Heuberger J, Novak R, Zohar Y, Beltran Lopez AP, Trausch-Azar JS, Ilagan MXG, Benhamou D, Dittmar G, Kopan R, Birchmeier W, Schwartz AL, Orian A.

Cell Rep. 2016 Sep 20;16(12):3388-3400. doi: 10.1016/j.celrep.2016.08.024.

5.

TLE4 regulation of wnt-mediated inflammation underlies its role as a tumor suppressor in myeloid leukemia.

Shin TH, Brynczka C, Dayyani F, Rivera MN, Sweetser DA.

Leuk Res. 2016 Sep;48:46-56. doi: 10.1016/j.leukres.2016.07.002. Epub 2016 Jul 21.

6.

MiR144/451 Expression Is Repressed by RUNX1 During Megakaryopoiesis and Disturbed by RUNX1/ETO.

Kohrs N, Kolodziej S, Kuvardina ON, Herglotz J, Yillah J, Herkt S, Piechatzek A, Salinas Riester G, Lingner T, Wichmann C, Bonig H, Seifried E, Platzbecker U, Medyouf H, Grez M, Lausen J.

PLoS Genet. 2016 Mar 18;12(3):e1005946. doi: 10.1371/journal.pgen.1005946. eCollection 2016 Mar.

7.

Synovial sarcoma: recent discoveries as a roadmap to new avenues for therapy.

Nielsen TO, Poulin NM, Ladanyi M.

Cancer Discov. 2015 Feb;5(2):124-34. doi: 10.1158/2159-8290.CD-14-1246. Epub 2015 Jan 22. Review.

8.

The DN2 Myeloid-T (DN2mt) Progenitor is a Target Cell for Leukemic Transformation by the TLX1 Oncogene.

Zweier-Renn LA, Riz I, Hawley TS, Hawley RG.

J Bone Marrow Res. 2013 Feb 20;1. pii: 105.

9.

Identification of a dynamic core transcriptional network in t(8;21) AML that regulates differentiation block and self-renewal.

Ptasinska A, Assi SA, Martinez-Soria N, Imperato MR, Piper J, Cauchy P, Pickin A, James SR, Hoogenkamp M, Williamson D, Wu M, Tenen DG, Ott S, Westhead DR, Cockerill PN, Heidenreich O, Bonifer C.

Cell Rep. 2014 Sep 25;8(6):1974-1988. doi: 10.1016/j.celrep.2014.08.024. Epub 2014 Sep 18.

10.

Overexpression of lymphoid enhancer-binding factor 1 (LEF1) in solid-pseudopapillary neoplasms of the pancreas.

Singhi AD, Lilo M, Hruban RH, Cressman KL, Fuhrer K, Seethala RR.

Mod Pathol. 2014 Oct;27(10):1355-63. doi: 10.1038/modpathol.2014.40. Epub 2014 Mar 21.

11.

Osr1 acts downstream of and interacts synergistically with Six2 to maintain nephron progenitor cells during kidney organogenesis.

Xu J, Liu H, Park JS, Lan Y, Jiang R.

Development. 2014 Apr;141(7):1442-52. doi: 10.1242/dev.103283. Epub 2014 Mar 5.

12.

Modulation of Wnt Activity and Cell Physiology by Butyrate in LT97 Microadenoma Cells.

Lazarova D, Lee A, Wong T, Marian B, Chiaro C, Rainey C, Bordonaro M.

J Cancer. 2014 Feb 14;5(3):203-13. doi: 10.7150/jca.8569. eCollection 2014.

13.

Transcription factor Runx3 regulates interleukin-15-dependent natural killer cell activation.

Levanon D, Negreanu V, Lotem J, Bone KR, Brenner O, Leshkowitz D, Groner Y.

Mol Cell Biol. 2014 Mar;34(6):1158-69. doi: 10.1128/MCB.01202-13. Epub 2014 Jan 13.

14.

Destabilization of heterologous proteins mediated by the GSK3β phosphorylation domain of the β-catenin protein.

Kong Y, Zhang H, Chen X, Zhang W, Zhao C, Wang N, Wu N, He Y, Nan G, Zhang H, Wen S, Deng F, Liao Z, Wu D, Zhang J, Qin X, Haydon RC, Luu HH, He TC, Zhou L.

Cell Physiol Biochem. 2013;32(5):1187-99. doi: 10.1159/000354518. Epub 2013 Nov 14.

15.

Runx transcription factors repress human and murine c-Myc expression in a DNA-binding and C-terminally dependent manner.

Jacobs PT, Cao L, Samon JB, Kane CA, Hedblom EE, Bowcock A, Telfer JC.

PLoS One. 2013 Jul 18;8(7):e69083. doi: 10.1371/journal.pone.0069083. Print 2013.

16.

GRG5/AES interacts with T-cell factor 4 (TCF4) and downregulates Wnt signaling in human cells and zebrafish embryos.

Costa AM, Pereira-Castro I, Ricardo E, Spencer F, Fisher S, da Costa LT.

PLoS One. 2013 Jul 1;8(7):e67694. doi: 10.1371/journal.pone.0067694. Print 2013.

17.

Development of GMDR-GPU for gene-gene interaction analysis and its application to WTCCC GWAS data for type 2 diabetes.

Zhu Z, Tong X, Zhu Z, Liang M, Cui W, Su K, Li MD, Zhu J.

PLoS One. 2013 Apr 23;8(4):e61943. doi: 10.1371/journal.pone.0061943. Print 2013.

18.

Foxg1 is required to limit the formation of ciliary margin tissue and Wnt/β-catenin signalling in the developing nasal retina of the mouse.

Fotaki V, Smith R, Pratt T, Price DJ.

Dev Biol. 2013 Aug 15;380(2):299-313. doi: 10.1016/j.ydbio.2013.04.017. Epub 2013 Apr 24.

19.

RUNX1: A microRNA hub in normal and malignant hematopoiesis.

Rossetti S, Sacchi N.

Int J Mol Sci. 2013 Jan 14;14(1):1566-88. doi: 10.3390/ijms14011566. Review.

20.

Novel function of the unique N-terminal region of RUNX1c in B cell growth regulation.

Brady G, Elgueta Karstegl C, Farrell PJ.

Nucleic Acids Res. 2013 Feb 1;41(3):1555-68. doi: 10.1093/nar/gks1273. Epub 2012 Dec 18.

Supplemental Content

Support Center